These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

958 related items for PubMed ID: 31391118

  • 1. Long non-coding RNA GAS5 inhibits DDP-resistance and tumor progression of epithelial ovarian cancer via GAS5-E2F4-PARP1-MAPK axis.
    Long X, Song K, Hu H, Tian Q, Wang W, Dong Q, Yin X, Di W.
    J Exp Clin Cancer Res; 2019 Aug 07; 38(1):345. PubMed ID: 31391118
    [Abstract] [Full Text] [Related]

  • 2. Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo.
    Zeng S, Liu S, Feng J, Gao J, Xue F.
    Cancer Biomark; 2019 Aug 07; 24(4):421-428. PubMed ID: 30909184
    [Abstract] [Full Text] [Related]

  • 3. [Bioinformatics analysis of drug-resistant ceRNA in epithelial ovarian cancer].
    Pan ZM, Tan FC, Chen CX, Zhang W, Li L.
    Zhonghua Fu Chan Ke Za Zhi; 2021 Feb 25; 56(2):121-130. PubMed ID: 33631884
    [Abstract] [Full Text] [Related]

  • 4. Long non-coding RNA LINC00337 induces autophagy and chemoresistance to cisplatin in esophageal squamous cell carcinoma cells via upregulation of TPX2 by recruiting E2F4.
    Yang C, Shen S, Zheng X, Ye K, Ge H, Sun Y, Lu Y.
    FASEB J; 2020 May 25; 34(5):6055-6069. PubMed ID: 32239565
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Long non-coding RNA GAS5 promotes cisplatin-chemosensitivity of osteosarcoma cells via microRNA-26b-5p/TP53INP1 axis.
    Li G, Yan X.
    J Orthop Surg Res; 2023 Nov 22; 18(1):890. PubMed ID: 37993867
    [Abstract] [Full Text] [Related]

  • 8. Upregulation of Long Noncoding RNA_GAS5 Suppresses Cell Proliferation and Metastasis in Laryngeal Cancer via Regulating PI3K/AKT/mTOR Signaling Pathway.
    Liu W, Zhan J, Zhong R, Li R, Sheng X, Xu M, Lu Z, Zhang S.
    Technol Cancer Res Treat; 2021 Nov 22; 20():1533033821990074. PubMed ID: 33641529
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Long non-coding RNA Linc00312 modulates the sensitivity of ovarian cancer to cisplatin via the Bcl-2/Caspase-3 signaling pathway.
    Zhang C, Wang M, Shi C, Shi F, Pei C.
    Biosci Trends; 2018 Jul 17; 12(3):309-316. PubMed ID: 29952351
    [Abstract] [Full Text] [Related]

  • 12. Down-regulation of long noncoding RNA DLX6-AS1 defines good prognosis and inhibits proliferation and metastasis in human epithelial ovarian cancer cells via Notch signaling pathway.
    Zhao J, Liu HR.
    Eur Rev Med Pharmacol Sci; 2019 Apr 17; 23(8):3243-3252. PubMed ID: 31081076
    [Abstract] [Full Text] [Related]

  • 13. Long non-coding RNA growth arrest-specific transcript 5 is involved in ovarian cancer cell apoptosis through the mitochondria-mediated apoptosis pathway.
    Gao J, Liu M, Zou Y, Mao M, Shen T, Zhang C, Song S, Sun M, Zhang S, Wang B, Zhu D, Li P.
    Oncol Rep; 2015 Dec 17; 34(6):3212-21. PubMed ID: 26503132
    [Abstract] [Full Text] [Related]

  • 14. Long non‑coding RNA CASC2 inhibits progression and predicts favorable prognosis in epithelial ovarian cancer.
    Xue Z, Zhu X, Teng Y.
    Mol Med Rep; 2018 Dec 17; 18(6):5173-5181. PubMed ID: 30320385
    [Abstract] [Full Text] [Related]

  • 15. Long noncoding RNA ZEB1-AS1 affects paclitaxel and cisplatin resistance by regulating MMP19 in epithelial ovarian cancer cells.
    Dai C, Xu P, Liu S, Xu S, Xu J, Fu Z, Cao J, Lv M, Zhou J, Liu G, Zhang H, Jia X.
    Arch Gynecol Obstet; 2021 May 17; 303(5):1271-1281. PubMed ID: 33151424
    [Abstract] [Full Text] [Related]

  • 16. LncRNA HAND2-AS1 represses cervical cancer progression by interaction with transcription factor E2F4 at the promoter of C16orf74.
    Gong J, Fan H, Deng J, Zhang Q.
    J Cell Mol Med; 2020 Jun 17; 24(11):6015-6027. PubMed ID: 32314545
    [Abstract] [Full Text] [Related]

  • 17. The long non-coding RNA, GAS5, enhances gefitinib-induced cell death in innate EGFR tyrosine kinase inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR via downregulation of the IGF-1R expression.
    Dong S, Qu X, Li W, Zhong X, Li P, Yang S, Chen X, Shao M, Zhang L.
    J Hematol Oncol; 2015 Apr 29; 8():43. PubMed ID: 25925741
    [Abstract] [Full Text] [Related]

  • 18. Downregulation of LINC01508 contributes to cisplatin resistance in ovarian cancer via the regulation of the Hippo-YAP pathway.
    Xiao L, Shi XY, Li ZL, Li M, Zhang MM, Yan SJ, Wei ZL.
    J Gynecol Oncol; 2021 Sep 29; 32(5):e77. PubMed ID: 34132072
    [Abstract] [Full Text] [Related]

  • 19. GAS5 knockdown reduces the chemo-sensitivity of non-small cell lung cancer (NSCLC) cell to cisplatin (DDP) through regulating miR-21/PTEN axis.
    Cao L, Chen J, Ou B, Liu C, Zou Y, Chen Q.
    Biomed Pharmacother; 2017 Sep 29; 93():570-579. PubMed ID: 28686971
    [Abstract] [Full Text] [Related]

  • 20. PARP1-DOT1L transcription axis drives acquired resistance to PARP inhibitor in ovarian cancer.
    Liu C, Li J, Xu F, Chen L, Ni M, Wu J, Zhao H, Wu Y, Li J, Wu X, Chen X.
    Mol Cancer; 2024 May 22; 23(1):111. PubMed ID: 38778348
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.